As of Jun 5, 2025, the Edwards Lifesciences stock's PE ratio is 11.06. This takes into account the latest EPS of $7.03 and stock price of $77.77. The PE ratio marks a decrease of 35% from its last 4 quarters average of 17.1.
The PE ratio of Edwards Lifesciences has averaged 40.97 over the last ten years. The current P/E ratio of 11.06 is 73% lower than the historical average. Looking back at the last ten years, EW's PE ratio peaked in the Dec 2020 quarter at 69.11, when the price was $91.23 and the EPS was $1.32. The lowest point was in the Sep 2024 quarter, when it reached 9.51 with a price of $65.99 and an EPS of $6.94.
Maximum annual increase: 104.49% in 2015
Maximum annual decrease: -67.86% in 2024
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 10.61 | -67.86% | $74.03 | $6.98 |
2023 | 33.01 | 8.84% | $76.25 | $2.31 |
2022 | 30.33 | -43.58% | $74.61 | $2.46 |
2021 | 53.76 | -22.21% | $129.55 | $2.41 |
2020 | 69.11 | 49.3% | $91.23 | $1.32 |
2019 | 46.29 | 4.26% | $77.76 | $1.68 |
2018 | 44.4 | 8.72% | $51.06 | $1.15 |
2017 | 40.84 | 16.39% | $37.57 | $0.92 |
2016 | 35.09 | 2.63% | $31.23 | $0.89 |
2015 | 34.19 | 104.49% | $26.33 | $0.77 |
2014 | 16.72 | -11.53% | $21.23 | $1.27 |
2013 | 18.9 | -47.18% | $10.96 | $0.58 |
2012 | 35.78 | 6.27% | $15.03 | $0.42 |
2011 | 33.67 | -20.02% | $11.78 | $0.35 |
2010 | 42.1 | 97.75% | $13.47 | $0.32 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 10.31 | -2.83% | $72.48 | $7.03 |
Dec 2024 | 10.61 | 11.57% | $74.03 | $6.98 |
Sep 2024 | 9.51 | -74.98% | $65.99 | $6.94 |
Jun 2024 | 38.01 | -7.32% | $92.37 | $2.43 |
Mar 2024 | 41.01 | 24.24% | $95.56 | $2.33 |
Dec 2023 | 33.01 | 11.97% | $76.25 | $2.31 |
Sep 2023 | 29.48 | -29.07% | $69.28 | $2.35 |
Jun 2023 | 41.56 | 21.06% | $94.33 | $2.27 |
Mar 2023 | 34.33 | 13.19% | $82.73 | $2.41 |
Dec 2022 | 30.33 | -14.1% | $74.61 | $2.46 |
Sep 2022 | 35.31 | -13.12% | $82.63 | $2.34 |
Jun 2022 | 40.64 | -14.39% | $95.09 | $2.34 |
Mar 2022 | 47.47 | -11.7% | $117.72 | $2.48 |
Dec 2021 | 53.76 | 12.54% | $129.55 | $2.41 |
Sep 2021 | 47.77 | 7.93% | $113.21 | $2.37 |
Currently, EW's PE ratio is lower than its 3, 5 and 10-year averages.
EW's PE ratio stands lower than its peer stocks BSX and MDT. Edwards Lifesciences is currently trading at a lower PE ratio (11.06) than its peers average of 46.91.
Stock name | PE ratio | Market cap |
---|---|---|
EW Edwards Lifesciences Corp | 11.04 | $45.53B |
MDT Medtronic plc | 26.34 | $111.82B |
LMAT Lemaitre Vascular Inc | 41.65 | $1.9B |
MMSI Merit Medical Systems Inc | 46.02 | $5.68B |
BSX Boston Scientific Corp | 74.44 | $151.98B |
ICUI Icu Medical Inc | N/A | $3.29B |
The price to earnings ratio for EW stock as of Jun 5, 2025, stands at 11.06.
The 3-year average price to earnings ratio for EW stock is 29.51.
The 5-year average price to earnings ratio for EW stock is 39.97.
The highest quarterly PE ratio in the last ten years has been 69.11 and it was in the Dec 2020 quarter.
EW's price to earnings ratio is currently 73% below its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 5, 2025), Edwards Lifesciences's share price is $77.77. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $7.03. Therefore, Edwards Lifesciences's PE ratio for today is 11.06. PE RATIO(11.06) = STOCK PRICE($77.77) / TTM EPS($7.03)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.